Mark J. Mulligan

1986–2025 年に発表

別表記
Mark J Mulligan
121
論文数
22,430
被引用数
70
h 指数
114
i10 指数

被引用数

Mark J. Mulligan の年別被引用数1988 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 3 件1993 年: 被引用 5 件1994 年: 被引用 13 件1995 年: 被引用 11 件1996 年: 被引用 16 件1997 年: 被引用 16 件1998 年: 被引用 26 件1999 年: 被引用 30 件2000 年: 被引用 22 件2001 年: 被引用 29 件2002 年: 被引用 43 件2003 年: 被引用 33 件2004 年: 被引用 50 件2005 年: 被引用 26 件2006 年: 被引用 40 件2007 年: 被引用 31 件2008 年: 被引用 28 件2009 年: 被引用 53 件2010 年: 被引用 68 件2011 年: 被引用 93 件2012 年: 被引用 98 件2013 年: 被引用 110 件2014 年: 被引用 116 件2015 年: 被引用 166 件2016 年: 被引用 163 件2017 年: 被引用 233 件2018 年: 被引用 219 件2019 年: 被引用 611 件2020 年: 被引用 851 件2021 年: 被引用 2,171 件2022 年: 被引用 1,432 件2023 年: 被引用 581 件2024 年: 被引用 737 件2025 年: 被引用 342 件2026 年: 被引用 13 件1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,696 件、この内訳の 31.3%中国: 引用元論文 821 件、この内訳の 7%イギリス: 引用元論文 804 件、この内訳の 6.8%ドイツ: 引用元論文 514 件、この内訳の 4.4%イタリア: 引用元論文 387 件、この内訳の 3.3%カナダ: 引用元論文 357 件、この内訳の 3%フランス: 引用元論文 354 件、この内訳の 3%オーストラリア: 引用元論文 332 件、この内訳の 2.8%スイス: 引用元論文 270 件、この内訳の 2.3%オランダ: 引用元論文 263 件、この内訳の 2.2%インド: 引用元論文 247 件、この内訳の 2.1%ブラジル: 引用元論文 206 件、この内訳の 1.8%
0%31.3%その他 30%

分野

  • Medicine65.2%
  • Immunology and Microbiology17.1%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Pharmacology, Toxicology and Pharmaceutics2.9%
  • Social Sciences0.8%
  • Mathematics0.5%
  • その他2.6%

トピック

  • SARS-CoV-2 and COVID-19 Research14.2%
  • COVID-19 Clinical Research Studies6.8%
  • Immunotherapy and Immune Responses4.2%
  • vaccines and immunoinformatics approaches3.6%
  • Immune Cell Function and Interaction3.4%
  • HIV Research and Treatment2.8%
  • その他65%

共著者

全論文

検索で開く
  1. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 2,730

  2. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 被引用: 1,594

  3. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

    著者: , , , , , , , , , , , , , , , , , , , - Nature Immunology 2013 被引用: 803

  4. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tina Tong, Margaret Brewinski Isaacs, David Benkeser, Holly E. Janes, Martha C. Nason, Justin A. Green, Elizabeth J. Kelly, Jill Maaske, Nancy Mueller, Kathryn Shoemaker, Therese Takas, Richard P. Marshall, Menelas N. Pangalos, Tonya Villafana, Antonio Gonzalez-Lopez - New England Journal of Medicine 2021 被引用: 683

  5. Homologous and Heterologous Covid-19 Booster Vaccinations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adrian B. McDermott, Sarah O’Connell, David C. Montefiori, Amanda Eaton, Kathleen M. Neuzil, David S. Stephens, Paul C. Roberts, John H. Beigel - New England Journal of Medicine 2022 被引用: 618

  6. Origin and differentiation of human memory CD8 T cells after vaccination

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 被引用: 533

  7. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 被引用: 424

  8. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franz J. Triana, J. Hendle, Anna Pustilnik, Andrew C. Adams, Shawn Berens, Ralph S. Baric, David R. Martinez, Robert W. Cross, Thomas W. Geisbert, Viktoriya Borisevich, Olubukola M. Abiona, Hayley M. Belli, Maren de Vries, Adil Mohamed, Meike Dittmann, Marie I. Samanovic, Mark J. Mulligan, Jory A. Goldsmith, Ching‐Lin Hsieh, Nicole V. Johnson, Daniel Wrapp, Jason S. McLellan, Bryan C. Barnhart, Barney S. Graham, John R. Mascola, Carl L. Hansen, Ester Falconer - Science Translational Medicine 2021 被引用: 497

  9. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

    著者: , , , , , , , , , , , , , , , , , , , - Nature Immunology 2008 被引用: 1,122

  10. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 585

  11. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Vaccine 2015 被引用: 148

  12. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2011 被引用: 802

  13. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David S. Stephens, Diane J. Post, Seema Nayak, Mehul S. Suthar, Paul C. Roberts, John H. Beigel, David C. Montefiori, Jennifer Husson, Angie Price, Jennifer A. Whitaker, Wendy A. Keitel, Ann R. Falsey, Ian Shannon, Daniel S. Graciaa, Nadine Rouphael, Evan J. Anderson, Satoshi Kamidani, Gysella Muñiz, Sonika Bhatnagar, Anna Wald, Megan Berman, Laura Porterfield, Amber Stanford, Jennifer Lee Dong, Steven E. Carsons, Diana Badillo, Susan Parker, Michelle Dickey, Sasha E. Larsen, John Hural, Brian Ingersoll, Marina Lee, Lilin Lai, Katharine Floyd, Madison Ellis, Kathryn M. Moore, Kelly E. Manning, Stephanie L. Foster, Mit Patel - Cell Reports Medicine 2022 被引用: 167

  14. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

    著者: , , , , , , , , , , , , , , , , , - Immunity 2015 被引用: 345

  15. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barney S. Graham, Theodore C. Pierson, Julie E. Ledgerwood, Grace Chen, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham, Olga Vasilenko, Maria Burgos Florez, Somia P. Hickman, Iris Pittman, Lam Le, Brenda Larkin, Charla Andrews, Preeti Apte, Renunda Hicks, Cora Trelles Cartagena, Pernell Williams, Catina Boyd, Michelle Conan-Cibotti, Judy Stein, Florence Kaltovich, Hope DeCederfelt, Stacey McAdams, Phyllis Renehan, Wilbur Chen, Nancy Greenberg, Nancy Wymer, Linda Wadsworth, Melissa Billington, Toni Robinson, Colleen Boyce, Faith Pa'ahana Brown, Lisa Chrisley, Alyson Kwon, Prashant Patel, Panagoita Kominou, Brenda Dorsey, Staci Eddington, Shinyi Telscher, Myoughee Lee, Regina Mosely, April Ross, Geoffrey Ford, Briyana Domjahn, Jianguo Xu, Allison Beck, Rebecca Fineman, Shiela Heeke, Jean M. Winter, Shashi Nagar, Colleen F. Kelley, Mark J. Mulligan, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham ほか 18 名 - The Lancet 2017 被引用: 304

  16. Metabolic Phenotypes of Response to Vaccination in Humans

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2017 被引用: 288

  17. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

    著者: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 245

  18. Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines

    著者: , , , , , , , , , , , , , , , , - Immunity 2008 被引用: 613

  19. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

    著者: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 被引用: 598

  20. The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

    著者: , , , , , , , , , , , , , , , - The Journal of Immunology 2009 被引用: 349

  21. The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention

    著者: , , , , , , , , , , , - Mucosal Immunology 2016 被引用: 191

  22. Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 被引用: 89

  23. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Price, Janelle Sabo, Jay Tuttle, Paul Klekotka, Lei Shen, Daniel Skovronsky, BLAZE-2 Investigators, Kwadwo-Agyei Gyamfi, Jason Begue, Scott Borgetti, Greer Burkholder, Srilatha Edupuganti, Kathleen Gannon, Christopher J. Hall, V. G. Horstman, Rubaba Hussain, Leandro Mena, Tina Merritt, C. Brendan Montano, Jason Morris, Meenakshi Patel, Ayesha Rashid, H. J. Solomon, Mousumi Som, George Taffet - JAMA 2021 被引用: 208

  24. Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity

    著者: , , , , , , - Vaccine 2020 被引用: 72